| abstract |
ABSTRACT There is described a mixture of 4-[2-(6-(2-phenyl-ethylamino)hexylamino)ethyl]-1,2-benzenediol, or 4-[2-(6-(2-chlorophenyl)ethylamino)hexylamino)ethyl]-1,2-benzenediol or a pharmaceutically acceptable acid addition salt of either thereof or as active ingredient, and a physiologically acceptable acid. There is also described a method of preparing a solid form of the active ingredient, which comprises freeze drying an aqueous solution of the mixture, and a freeze dried composition containing the active ingredient prepared by the method. The mixtures are useful as pharmaceuticals, e.g. in the treatment of cardiovascular conditions. |